Elizabeth Garrett-Mayer to Angiopoietin-2
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Angiopoietin-2.
Connection Strength
0.024
-
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 2012; 82(2):67-74.
Score: 0.024
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.